FcRH5 | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights Trial results

23 September 2025

Roche pushes a novel myeloma target

The company will be the first to take a FcRH5-targeting project into phase 3.

Subscribe to FcRH5